David Bartlett, MD, joins Pittsburgh-based AHN after serving several leadership roles at Highmark’s Pittsburgh rival, UPMC. During his tenure at UPMC, Dr. Bartlett served as vice chair for surgical oncology and gastrointestinal surgery services, director of the David C. Koch Regional Perfusion Cancer Therapy Center, chief of surgery for Shadyside Hospital in Pittsburgh, and the Bernard Fisher Professor of Surgery at the University of Pittsburgh School of Medicine.
As chair of the AHN Cancer Institute, Dr. Bartlett will lead more than 200 physicians and 500 advanced-practice oncology professionals. The institute is undergoing significant growth projects, including the opening of an $80 million academic center at Allegheny General Hospital in Pittsburgh.
Effective in spring 2020, Dr. Bartlett will succeed David Parda, MD, who was named president of AGH in October.
More articles on leadership and management:
How to break down silos and foster collaboration across the C-suite: 3 notes
Nashville General loses 3 board members
Crises push number of corporate giants separating CEO, chairman roles to record level
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.